Drug Discovery, Molecular Design, SAR Studies, Lead Optimization
An observational study showed that GLP-1 agonists decreased the risks of different types of cancer in people with obesity
medpagetoday.com·1d
Scientists Are Fighting Future Pandemics With a Secret Weapon: Airplane Toilets
popularmechanics.com·3d
Smooze_Pro_2.2.6_TNT.dmg
xmac.app·3h
Is Danaher Corporation (DHR) a Quality Compounder With Long-Term Revenue Growth?
finance.yahoo.com·1d
Game Crossovers
bluesnews.com·1d
Trial By Error: Keystone Gathering Update; Anil’s Severe ME Day Video; Fractured Care for Post-Infectious Illness
virology.ws·3d
Book Review: ‘Positive Obsession: The Life and Times of Octavia E. Butler,’ by Susana M. Morris
nytimes.com·1d
Pomerantz Law Firm Announces the Filing of a Class Action Against Biohaven Ltd. and Certain Officers - BHVN
prnewswire.com·2d
INVESTOR DEADLINE MONDAY: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - SRPT
prnewswire.com·2d
Precision Timing System Calibration for Deep Inelastic Scattering Experiments Using Machine Learning
12.6% CAGR for Cancer Drugs Market to Reach US$516.15 billion by 2031, Due to Surging Investments in Oncology Research | The Insight Partners
prnewswire.com·5d
Loading...Loading more...